Spots Global Cancer Trial Database for Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer
Official Title: Observational Study - Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Tubular Carcinoma
Study ID: NCT00947102
Conditions
Interventions
Study Description
Brief Summary: Observational study of influence of gemcitabine treatment on serological and immunological status and gene expression profile in patients with pancreatic tubular carcinoma after tumor resection.
Detailed Description:
Eligibility
Minimum Age: 30 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University Medical Centre Ljubljana; Department for Gastroenterology, Ljubljana, , Slovenia
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
